MTOR and metabolic dysfunction-associated steatohepatitis: These results are in line with the body of evidence that established the importance of the PI3K-AKT-mTOR axis in determining liver fibrosis and with 2 previous reports assessing the role of p70S6K in a rodent NASH model27 and in bile acid–induced activation of HSCs.28